Estradiol / Norethindrone Uses, Dosage, Side Effects and Interactions
Lopreeza
Lopreeza is a brand of estradiol / norethindrone that comes as a tablet. An FDA-approved generic with the same active ingredients is listed.
Activella
Activella was the first estradiol / norethindrone product the FDA approved, in November 1998. An FDA-approved generic with the same active ingredients is listed.
Etyqa
Etyqa is a generic estradiol / norethindrone sold under its own name, approved by the FDA in June 2023. An FDA-approved generic with the same active ingredients is listed.
Abigale
Abigale is a brand of estradiol / norethindrone that comes as a tablet. An FDA-approved generic with the same active ingredients is listed.
Abigale Lo
Abigale Lo is a brand of estradiol / norethindrone that comes as a tablet. An FDA-approved generic with the same active ingredients is listed.
Mimvey
Mimvey is a brand of estradiol / norethindrone that comes as a tablet. An FDA-approved generic with the same active ingredients is listed.
Amabelz
Amabelz is a generic estradiol / norethindrone sold under its own name, approved by the FDA in June 2016. It is not in the FDA’s directory today; generic estradiol / norethindrone is.
Estradiol / norethindrone is a combination estrogen and progestin hormone therapy used to treat moderate to severe menopausal symptoms and to help prevent postmenopausal osteoporosis.
Quick links
Ask Anything About Estradiol / NorethindroneType a question in your own words. Answered from its FDA label in seconds.Every other section of this page is in the dots on the left edge of your screen: point at one to see where it goes.Every other section of this page is one tap away: use the arrow tab on the left edge of your screen.
Estradiol / Norethindrone in Short
- Drug classes Estrogen; Progestin How the FDA classifies it
What it treatsThis combination of estradiol (an estrogen) and norethindrone acetate (a progestin) is used in postmenopausal women who still have a uterus. It treats moderate to severe vasomotor symptoms (hot flashes and night sweats) due to menopause, and moderate to severe symptoms of vulvar and vaginal atrophy (vaginal dryness…
- How you get it Prescription only
- Comes asTablet and skin patchAvailable strengths (estradiol/norethindrone)
Tablet (by mouth)
- 0.5 mg/0.1 mg
- 1 mg/0.5 mg
Skin patch (through the skin)
- 0.05 mg/d / 0.14 mg/d
- 0.05 mg/d / 0.25 mg/d
- The FDA’s strongest warningBoxed warning The FDA’s most serious alert. Read what it says
- What pharmacies pay
- Generic$0.55 to $0.59 a tablet
- Skin patches, brand name: $31.79 to $31.80 each
- Generic versionYes, FDA-approved Listed with the FDA, which does not mean every pharmacy stocks it
The Pharmacist’s Take
Estradiol / norethindrone is a long-standing combined hormone therapy for women with a uterus, treating moderate to severe hot flashes and vaginal dryness from menopause and helping prevent bone thinning; estradiol replaces lost estrogen while norethindrone, a progestin, protects the uterine lining, and it has been on the U.S. market since about 1998 with FDA-approved generics listed. Most women tolerate it reasonably well, and breast tenderness and spotting are what people notice most, often in the first months. Its boxed warning covers blood clots, stroke, heart attack, breast cancer and, from age 65, probable dementia, so use the lowest dose that works for as short a time as needed. Review at every checkup whether you still need it.
Key Takeaways From the HelloPharmacist Team
- Take the tablet once a day, with or without food; the patch version is changed twice a week, rotating where you place it.
- Expect some spotting or breast tenderness early on, but get any unexplained or new vaginal bleeding checked promptly.
- Get emergency care for sudden leg pain or swelling, chest pain, shortness of breath, trouble speaking, or sudden vision loss.
- Stay current on mammograms and report any new breast lump, since this combination raises breast cancer risk.
FDA Boxed WarningThe FDA’s strongest safety alert. Read what it says about Estradiol / Norethindrone.
This medicine carries a serious FDA boxed warning about cancer, heart problems, and dementia. Taking estrogen plus progestin has been linked to a higher risk of heart attack, stroke, blood clots (deep vein thrombosis and pulmonary embolism), and invasive breast cancer. Studies in women 65 and older also found a higher risk of probable dementia. Do not use this medicine to prevent heart disease, stroke, or dementia — it is not approved for those purposes and may actually increase those risks. Using estrogen alone (without a progestin) in women who still have a uterus raises the risk of uterine (endometrial) cancer. The risks of estrogen plus progestin therapy were studied primarily with one specific product and dose; how much these risks apply to other products and doses, including this one, is not fully known. Talk with your doctor regularly about whether the benefits still outweigh the risks for you personally.
Patient Information Guide for Estradiol / Norethindrone
What It’s Used For
Estradiol / norethindrone is a combination hormone therapy approved for postmenopausal women who still have a uterus. Here is the full set of supported uses across available products:
- Moderate to severe vasomotor symptoms (hot flashes, night sweats) due to menopause — supported by all oral tablet products and CombiPatch
- Moderate to severe vulvar and vaginal atrophy symptoms (dryness, irritation, painful intercourse) due to menopause — supported by all oral tablet products and CombiPatch; topical vaginal products should be considered first if this is the only reason for treatment
- Prevention of postmenopausal osteoporosis (bone thinning after menopause) — supported by oral tablet products; non-estrogen medications should be considered first if osteoporosis prevention is the sole reason for use, and estrogen should be reserved for women at significant risk
- CombiPatch (the transdermal patch) is additionally approved for treatment of low estrogen due to hypogonadism (underactive ovaries), castration, or primary ovarian failure
How It Works
After menopause, estrogen levels drop sharply. Estradiol is the main active estrogen in the body — it binds to estrogen receptors in tissues like the brain, vagina, and bone, helping to ease hot flashes, reverse vaginal changes, and slow the bone loss that follows menopause. Norethindrone acetate is a progestin (a synthetic progesterone-like hormone) that balances estrogen's effects on the uterine lining, reducing the risk of abnormal tissue growth (endometrial hyperplasia) that can develop when estrogen is used alone.
The progestin component works by binding to progesterone receptors, which counteract estrogen's stimulating effect on the uterus and help reduce estrogen receptor activity in target tissues.
Drug Class
Drug Class
- Estrogen from estradiol
- Progestin from norethindrone
Detailed classifications and sources
The FDA sorts a drug’s active ingredient by how it works, what it does in the body and its chemical structure, and gives it one main drug class. Estradiol / Norethindrone has two active ingredients, so each class says which one it comes from.
Drug Class
Established Pharmacologic Class (EPC)- Estrogen from estradiol
- Progestin from norethindrone
The main drug class the FDA gives it. It is the class named on the drug’s label.
How It Works
Mechanism of action (MoA)- Estrogen Receptor Agonists from estradiol
What it does at the smallest level, such as a receptor or enzyme it blocks or switches on.
What It Does in the Body
Physiologic effect (PE)None listed for Estradiol / Norethindrone in the FDA’s index.
From our Patient Information GuideAfter menopause, estrogen levels drop sharply. Estradiol is the main active estrogen in the body — it binds to estrogen receptors in tissues like the brain, vagina, and bone, helping to ease hot flashes, reverse vaginal changes, and slow the bone loss that follows menopause. Read How Estradiol / Norethindrone Works
A change it makes in how the body works.
Chemical Family
Chemical structure (CS)- Estradiol Congeners from estradiol
- Progesterone Congeners from norethindrone
The chemical family it belongs to, by its structure.
Drug Family
WHO ATC classification- Natural and semisynthetic estrogens, plain from estradiol
- Progestogens from norethindrone
- Estren derivatives from norethindrone
How the World Health Organization groups it: by the part of the body it acts on and what it treats.
The classes are the FDA’s own words, from its index of drug labels, published in the National Library of Medicine’s RxClass. The description under What It Does in the Body is written by the HelloPharmacist team, not the FDA. Read the FDA’s definitions. The drug family is the World Health Organization’s ATC classification. Reference only, not medical advice.
Dosage
Oral tablets are taken once daily by mouth. Taking the tablet with food does not meaningfully affect how estradiol is absorbed, though it may slightly alter the absorption profile of norethindrone.
CombiPatch (the transdermal patch) is applied to the skin twice weekly on a rotating site. All forms should be used at the lowest dose that controls your symptoms, for the shortest time that meets your goals — your doctor should reassess this at regular visits.
- Oral tablets: once daily, with or without food
- CombiPatch: applied to skin, changed twice weekly, rotating sites
- Never adjust your dose on your own — always follow your prescriber's instructions
Typical Doses
Your prescriber chooses your dose, so take it exactly as prescribed.
Estradiol / Norethindrone Skin Patch
Menopause symptoms in women with a uterus
Women with a uterus · Continuous sequential regimen Starting dose 0.05 mg per day of estradiol (Vivelle-Dot patch) every 3 to 4 days for the first 14 days Usual dose 1 patch (0.05 mg estradiol/0.14 mg NETA per day) every 3 to 4 days for the remaining 14 days
Step by step
- Days 1 to 14 of a 28-day cycle: 0.05 mg per day estradiol transdermal system (Vivelle-Dot), replaced every 3 to 4 days (twice weekly)
- Remaining 14 days: CombiPatch 0.05 mg estradiol/0.14 mg NETA per day (9 cm2) worn continuously on the lower abdomen, replaced every 3 to 4 days (twice weekly)
Good to Know for Every Dose
0.05 mg estradiol/0.25 mg NETA (16 cm2 system) is available if a greater progestin dose is desired
Estradiol / Norethindrone Taken by Mouth
Hot flashes and night sweats from menopause
For women after menopause Usual dose 1 tablet once a dayVaginal and vulvar dryness and thinning from menopause
For women after menopause Usual dose 1 tablet (1 mg/0.5 mg) once a dayPreventing bone thinning after menopause
For women after menopause Usual dose 1 tablet once a day
Side Effects
The most commonly reported side effects with oral estradiol / norethindrone acetate tablets include:
Common side effects
- Breast pain or tenderness
- Headache
- Nausea
- Back pain
- Vaginal bleeding or spotting
- Upper respiratory tract infections
- Insomnia
- Weight gain
- Vaginal bleeding or spotting after menopause
- Sinus congestion (sinusitis)
- Emotional changes or mood swings
When to get medical help
- Signs of blood clot: sudden leg pain or swelling, chest pain, shortness of breath, or coughing up blood — seek emergency care immediately
- Signs of stroke: sudden numbness, severe headache, trouble speaking, or vision changes — call 911
- Signs of heart attack: chest pain, pain spreading to the arm or jaw, sweating — call 911
- Sudden partial or complete vision loss — stop the medicine and get medical help right away
- Unusual lumps in the breast or changes on mammogram — tell your doctor
- Unexplained vaginal bleeding — contact your doctor promptly
- Severe allergic reaction (swelling of the face, lips, tongue, or throat, hives, difficulty breathing) — seek emergency care
Warnings and Precautions
- Blood clots, stroke, and heart attack: Estrogen plus progestin therapy raises the risk of DVT (deep vein thrombosis), PE (pulmonary embolism), stroke, and heart attack. Stop this medicine immediately and seek emergency care if you develop sudden leg pain or swelling, chest pain, shortness of breath, or signs of stroke. Estrogen should be stopped at least 4 to 6 weeks before major surgery or extended bed rest.
- Breast cancer: Combined estrogen plus progestin therapy has been linked to an increased risk of invasive breast cancer. Get yearly breast exams and mammograms as recommended. Report any new breast lumps to your doctor.
- Uterine (endometrial) cancer: Using estrogen without a progestin in women who have a uterus increases endometrial cancer risk. The norethindrone in this combination helps reduce — but does not eliminate — that risk. Report any unexpected vaginal bleeding to your doctor promptly.
- Ovarian cancer: Hormone therapy has been associated with a modestly increased risk of ovarian cancer based on study data.
- Dementia: In women 65 and older, combined hormone therapy was linked to a higher risk of probable dementia. This medicine should not be used to prevent dementia.
- Gallbladder disease: Estrogen therapy raises the risk of gallbladder disease requiring surgery by 2 to 4 times.
- Liver disease: Do not use if you have active liver disease. Stop the medicine if cholestatic jaundice (yellowing of the skin due to bile flow problems) occurs.
- Vision changes: Retinal vascular thrombosis (a blood clot in the eye) has been reported. Stop the medicine and get an eye exam immediately if you have sudden vision loss or eye pain.
Interactions
Several medicines and supplements can raise or lower hormone levels when taken with estradiol / norethindrone:
- St. John's wort (herbal supplement) — speeds up hormone breakdown, which can lower hormone levels and reduce effectiveness or cause irregular bleeding
- Seizure medicines (phenobarbital, carbamazepine) and rifampin (antibiotic) — also speed up breakdown of estradiol and norethindrone, potentially reducing their effect
- Antifungal medicines (ketoconazole, itraconazole) and antibiotics (erythromycin, clarithromycin) — slow hormone breakdown, which can raise levels and increase side effects
- Ritonavir (HIV medicine) — may increase hormone levels in the blood
- Grapefruit juice — may raise estradiol levels by slowing its breakdown in the gut and liver
Interactions Listed in the FDA-Approved Label
From the Estradiol / Norethindrone prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.
-
CYP3A4 inducers (St. John's wort, phenobarbital, carbamazepine, rifampin)What happensMay reduce plasma concentrations of estrogens, possibly decreasing therapeutic effects and/or changing the uterine bleeding profile.
-
CYP3A4 inhibitors (erythromycin, clarithromycin, ketoconazole, itraconazole, ritonavir, grapefruit juice)What happensMay increase plasma concentrations of estrogens and result in adverse reactions.
-
Drugs or herbal products that induce or inhibit cytochrome P-450 enzymes, including CYP3A4 (norethindrone acetate)What happensMay decrease or increase the serum concentrations of norethindrone.
Read the label’s full interactions text
7 DRUG INTERACTIONS Co-administration of estradiol with norethindrone acetate did not elicit any apparent influence on the pharmacokinetics of norethindrone acetate. Similarly, no relevant interaction of norethindrone acetate on the pharmacokinetics of estradiol was found within the NETA dose range investigated in a single dose study. Estradiol In-vitro and in-vivo studies have shown that estrogens are metabolized partially by cytochrome P450 3A4 (CYP3A4). Therefore, inducers or inhibitors of CYP3A4 may affect estrogen drug metabolism. Inducers of CYP3A4 such as St. John’s wort ( Hypericum perforatum ) preparations, phenobarbital, carbamazepine, and rifampin may reduce plasma concentrations of estrogens, possibly resulting in a decrease in therapeutic effects and/or changes in the uterine bleeding profile. Inhibitors of CYP3A4 such as erythromycin, clarithromycin, ketoconazole, itraconazole, ritonavir and grapefruit juice may increase plasma concentrations of estrogens and result in adverse reactions. Norethindrone Acetate Drugs or herbal products that induce or inhibit cytochrome P-450 enzymes, including CYP3A4, may decrease or increase the serum concentrations of norethindrone. Inducers and/or inhibitors of CYP3A4 may affect estrogen drug metabolism and decrease or increase the estrogen plasma concentration.
Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.
Before You Start
- Do not use if you have unexplained or undiagnosed vaginal bleeding
- Do not use if you have or have had breast cancer, or other estrogen-dependent cancers
- Do not use if you have active blood clots (DVT or PE) or a history of them
- Do not use if you have had a stroke or heart attack, or have active arterial blood clot disease
- Do not use if you have active liver disease or liver impairment
- Do not use if you have an inherited clotting disorder (protein C, protein S, or antithrombin deficiency, or other thrombophilic conditions)
- Do not use if you have had a severe allergic reaction (anaphylaxis or angioedema) to this medicine
- Women 65 and older face higher risks of stroke, breast cancer, and probable dementia — discuss carefully with your doctor
- Not for use during pregnancy or in children
- Tell your doctor if you are breastfeeding — this medicine passes into breast milk and may reduce milk supply
- Tell your doctor if you take thyroid replacement hormone — estrogen can affect thyroid function tests and may require dose adjustments of thyroid medicine
Overdose
Taking too much of this medicine may cause nausea, vomiting, breast tenderness, abdominal pain, drowsiness, fatigue, and possibly unexpected vaginal bleeding. If an overdose is suspected, stop taking the medicine and contact a healthcare provider or poison control center for guidance on appropriate care.
How Your Body Processes It
After swallowing an oral tablet, estradiol is absorbed through the gastrointestinal tract and reaches peak blood levels within about 5 to 8 hours; norethindrone acetate is quickly converted to norethindrone and peaks within about 30 to 90 minutes. With daily dosing, steady-state blood levels are reached within about two weeks. Both hormones are mostly bound to proteins in the blood (albumin and SHBG) and are broken down primarily in the liver. Estradiol is metabolized into estrone and estriol, which are less active, and both estradiol and norethindrone are eventually excreted in urine and bile. Food does not significantly change how much estradiol is absorbed from the tablet, but it does modestly alter the absorption profile of norethindrone.
Storage
Store in a dry place protected from light. Store at 20° to 25°C (68° to 77°F), excursions permitted between 15° to 30°C (59° to 86°F) .
Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI
Estradiol / Norethindrone: Pharmacist Answers to Common Questions
Quick, plain-English answers to the questions patients ask most about Estradiol / Norethindrone — the kind of thing our pharmacy team would talk through with you at the counter.
What exactly is this medicine doing for me — why do I need both an estrogen and a progestin?
What are the most important side effects I should actually watch out for?
I've heard hormone therapy can cause cancer. How worried should I be?
Are there any supplements or medications I should avoid while taking this?
How long will I need to take this, and will I know when to stop?
Is it safe to take this if I'm over 65?
Is estradiol / norethindrone available over the counter?
When was estradiol / norethindrone first available?
Who makes estradiol / norethindrone?
What is the brand name of estradiol / norethindrone?
What is the generic name of Lopreeza?
What drug class is estradiol / norethindrone?
Is there a generic version of estradiol / norethindrone?
What strengths does estradiol / norethindrone come in?
How much does estradiol / norethindrone cost?
Where can I read the estradiol / norethindrone prescribing information (package insert)?
Is estradiol / norethindrone gluten free?
Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI
Ask Anything About Estradiol / Norethindrone
Skip the scrolling. Ask in your own words and get an answer from Estradiol / Norethindrone’s FDA label and our pharmacists’ own work.
Name another drug or a supplement in your question and we check both.
AI answers from FDA labels and our own records, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.How this works
- Sources: Estradiol / Norethindrone’s FDA label, including the clinical studies it reports, and the label of any drug you name; our pharmacists’ own work, such as our Do Not Crush list and our published answers to readers’ questions; our pharmacy prices and the Natural Medicines supplement database.
- Written by AI: Answers are written by AI from those sources, and AI can make mistakes. Check what you read here with your doctor or pharmacist before you act on it.
- Reviewed afterward: Our pharmacy team reviews every question and answer afterward to check it for accuracy, and when we find an error, we correct how the box answers. Read more in How we use AI.
- Not medical advice. In an emergency, call 911, Poison Control at 1-800-222-1222, or 988.
More About Estradiol / Norethindrone on HelloPharmacist
Still have a question? A licensed pharmacist answers for free, as soon as they can.Estradiol / Norethindrone Forms and Strengths (How It Comes)
Estradiol / Norethindrone comes in 2 dose forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Estradiol / Norethindrone inactive ingredients by manufacturer.
Tablet
How this form is used
- Treats moderate to severe hot flashes and night sweats (vasomotor symptoms) due to menopause
- Treats moderate to severe vaginal dryness and irritation (vulvar and vaginal atrophy) due to menopause
- Helps prevent postmenopausal osteoporosis (bone loss after menopause)
- Indicated for women who still have a uterus — the progestin component helps protect the uterine lining
- Abigale, Abigale Lo, Activella, and other oral tablets are taken once daily by mouth
- Tablets may be taken with or without food; taking with food may slightly reduce the peak level of norethindrone but does not meaningfully change overall absorption of estradiol
- Use the lowest effective dose for the shortest duration consistent with your treatment goals — discuss regularly with your doctor
- Do not stop or adjust your dose without talking to your prescriber first
Skin patch
How this form is used
- CombiPatch treats moderate to severe vasomotor symptoms (hot flashes, night sweats) due to menopause
- CombiPatch treats moderate to severe symptoms of vulvar and vaginal atrophy due to menopause
- CombiPatch is indicated for low estrogen levels caused by hypogonadism (underactive ovaries), castration, or primary ovarian failure
- CombiPatch is indicated for women with a uterus; when used only for vaginal symptoms, topical vaginal products should be considered first
- CombiPatch is applied to the skin (transdermal) and worn continuously; apply twice weekly
- CombiPatch should be started at the lowest dose; your prescriber will determine the appropriate regimen
- Rotate the application site with each new patch to avoid skin irritation
- CombiPatch should be used at the lowest effective dose for the shortest duration — your doctor should reassess your need for treatment periodically
Estradiol / Norethindrone on the U.S. Market: Products, Makers and Brands
How Estradiol / Norethindrone appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
10 companies list 20 Estradiol / Norethindrone product records with the FDA, mostly as tablet, skin patch; the earliest marketing or approval year on record is 1998. Brand names in the directory today include Lopreeza, Activella, Etyqa and 3 more; the rest are generics.
FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
How Widely Estradiol / Norethindrone Is Used (Medicaid Data)
How many Estradiol / Norethindrone prescriptions Medicaid paid for in Q1–Q4 2025, every brand, strength and form together. Medicaid is one program, so total U.S. use is higher.
How commonly is Estradiol / Norethindrone prescribed? Of the 1,682 medications we measure, Estradiol / Norethindrone ranks #685 by Medicaid prescriptions — more than 59% of them.
Utilization by Estradiol / Norethindrone product
Pick a strength and form to see its own numbers. Brand and generic versions are counted together.
84 HR estradiol 0.00208 MG/HR / norethindrone acetate 0.00583 MG/HR Transdermal System Most dispensed
1 of 2 listed NDCs had Medicaid claims. RxNorm 1251493
84 HR estradiol 0.00208 MG/HR / norethindrone acetate 0.0104 MG/HR Transdermal System
1 of 2 listed NDCs had Medicaid claims. RxNorm 1251499
Other Estradiol / Norethindrone products: packs and listings not matched to one strength and form
11 of 34 listed NDCs had Medicaid claims.
Dollars are what Medicaid paid before the rebates drug makers send back, so its real cost is lower.
Source: Medicaid State Drug Utilization Data (CMS), all states. 13 of the 38 listed Estradiol / Norethindrone NDCs had Medicaid claims.
Compare Estradiol / Norethindrone Products
A representative set of FDA-listed product records for Estradiol / Norethindrone — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Skin patch | ||||
| ESTRADIOL 0.05 mg/d; NORETHINDRONE ACETATE 0.14 mg/d | Transdermal | Noven Therapeutics, LLC | NDA | View NDC → |
| ESTRADIOL 0.05 mg/d; NORETHINDRONE ACETATE 0.25 mg/d | Transdermal | Noven Therapeutics, LLC | NDA | View NDC → |
| 💊Tablet | ||||
| ESTRADIOL 0.5 mg/1; NORETHINDRONE ACETATE 0.1 mg | Oral | A-S Medication Solutions | ANDA | View NDC → |
| ESTRADIOL 1 mg/1; NORETHINDRONE ACETATE 0.5 mg | Oral | A-S Medication Solutions | ANDA | View NDC → |
| ESTRADIOL 0.5 mg/1; NORETHINDRONE ACETATE 0.1 mg | Oral | Amneal Pharmaceuticals LLC | NDA | View NDC → |
| ESTRADIOL 1 mg/1; NORETHINDRONE ACETATE 0.5 mg | Oral | Amneal Pharmaceuticals LLC | NDA | View NDC → |
| ESTRADIOL 0.5 mg/1; NORETHINDRONE ACETATE 0.1 mg | Oral | Amneal Pharmaceuticals NY LLC | NDA | View NDC → |
| ESTRADIOL 0.5 mg/1; NORETHINDRONE ACETATE 0.1 mg | Oral | Amneal Pharmaceuticals NY LLC | NDA AUTHORIZED GENERIC | View NDC → |
| ESTRADIOL 1 mg/1; NORETHINDRONE ACETATE 0.5 mg | Oral | Amneal Pharmaceuticals NY LLC | NDA | View NDC → |
| ESTRADIOL 1 mg/1; NORETHINDRONE ACETATE 0.5 mg | Oral | Amneal Pharmaceuticals NY LLC | NDA AUTHORIZED GENERIC | View NDC → |
| ESTRADIOL 0.5 mg/1; NORETHINDRONE ACETATE 0.1 mg | Oral | Aurobindo Pharma Limited | ANDA | View NDC → |
| ESTRADIOL 1 mg/1; NORETHINDRONE ACETATE 0.5 mg | Oral | Aurobindo Pharma Limited | ANDA | View NDC → |
| ESTRADIOL 0.5 mg/1; NORETHINDRONE ACETATE 0.1 mg | Oral | Breckenridge Pharmaceutical, Inc. | ANDA | View NDC → |
| ESTRADIOL 1 mg/1; NORETHINDRONE ACETATE 0.5 mg | Oral | Breckenridge Pharmaceutical, Inc. | ANDA | View NDC → |
| ESTRADIOL 0.5 mg/1; NORETHINDRONE ACETATE 0.1 mg | Oral | Ingenus Pharmaceuticals, LLC | ANDA | View NDC → |
| ESTRADIOL 1 mg/1; NORETHINDRONE ACETATE 0.5 mg | Oral | Ingenus Pharmaceuticals, LLC | ANDA | View NDC → |
| NORETHINDRONE ACETATE 0.5 mg/1; ESTRADIOL 1 mg | Oral | Naari Pte. Limited | ANDA | View NDC → |
| ESTRADIOL 1 mg/1; NORETHINDRONE ACETATE 0.5 mg | Oral | Teva Pharmaceuticals USA, Inc. | ANDA | View NDC → |
| ESTRADIOL 0.5 mg/1; NORETHINDRONE ACETATE 0.1 mg | Oral | Xiromed LLC | ANDA | View NDC → |
| ESTRADIOL 1 mg/1; NORETHINDRONE ACETATE 0.5 mg | Oral | Xiromed LLC | ANDA | View NDC → |
Showing 20 of 20 products — FDA National Drug Code Directory.
Estradiol / Norethindrone Side Effects Reported to the FDA (FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Estradiol / Norethindrone — a signal of what to watch for, not proof the drug caused it.
The effects most often named in FDA reports that mention Estradiol / Norethindrone are breast cancer, breast cancer female, fatigue; about 74% of the reports were classed as serious. These are voluntary reports, so they show what people report, not how often it happens.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Estradiol / Norethindrone in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
Estradiol / Norethindrone FDA Approval History
How Estradiol / Norethindrone went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Estradiol / Norethindrone was first approved by the FDA in 1998. It remains available in U.S. pharmacies today.
Source: Drugs@FDA.
Estradiol / Norethindrone Recall History
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
The FDA’s enforcement reports list no Estradiol / Norethindrone recalls since July 2021.
✅No Estradiol / Norethindrone recalls on record since July 2021Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Nov 19, 2026.
Estradiol / Norethindrone in RxNorm: From Ingredient to Every Form and Strength
RxNorm is the U.S. National Library of Medicine’s standard name for every version of a medicine, the code pharmacy and prescribing systems share. This page starts from one exact combination of ingredients (MIN); each dose form (SCDF) branches from it, and each exact strength (SCD) from its form. A different combination is a different concept with its own page.
- Dose forms
- 2
- Strengths
- 7
- Forms in current FDA listings
- 2 of 2
RxCUI 214551 -
Dose form (SCDF) Oral TabletIn current FDA listings
RxCUI 372073Its 4 strengths (SCD)-
estradiol 0.5 mg / norethindrone acetate 0.1 mg
RxCUI 1359123 -
estradiol 1 mg / norethindrone acetate 0.5 mg
RxCUI 1359126 -
estradiol 2 mg / norethindrone 0.7 mg
RxCUI 250838 -
estradiol 2 mg / norethindrone 1 mg
RxCUI 249869
-
estradiol 0.5 mg / norethindrone acetate 0.1 mg
-
Dose form (SCDF) Transdermal SystemIn current FDA listings
RxCUI 1806052Its 3 strengths (SCD)-
84 hr estradiol 0.00208 mg/hr / norethindrone acetate 0.00583 mg/hr
RxCUI 1251493 -
84 hr estradiol 0.00208 mg/hr / norethindrone acetate 0.00708 mg/hr
RxCUI 1359291 -
84 hr estradiol 0.00208 mg/hr / norethindrone acetate 0.0104 mg/hr
RxCUI 1251499
-
84 hr estradiol 0.00208 mg/hr / norethindrone acetate 0.00583 mg/hr
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
Estradiol / Norethindrone Supply and Shortage Status
Whether Estradiol / Norethindrone is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
What Estradiol / Norethindrone Costs Pharmacies (NADAC Benchmark)
What pharmacies pay to buy Estradiol / Norethindrone: the national average from CMS’s weekly NADAC survey, as of Nov 18, 2026. It is the pharmacy’s cost, not your price at the counter.
How the Pharmacy Price Has Changed
Pick a form and a strength to see how its price has changed since Nov 2023.
For the generic ESTRADIOL 0.5 mg/1; NORETHINDRONE ACETATE 0.1 mg tablet, pharmacies paid an average of $0.593 per tablet as of Nov 18, 2026, down 20% from $0.741 a year earlier.
- What pharmacies pay now
- $0.593
- per tablet, as of Nov 18, 2026
- Last 4 weeks
- Down 17%
- from $0.712 on Oct 21, 2026
- Last 12 months
- Down 20%
- from $0.741 on Nov 19, 2025
- Lowest and highest since Nov 2023
- $0.405 to $0.967
- per tablet
See the numbers, month by month
| Month | Pharmacy price |
|---|---|
| Nov 2026 | $0.593 |
| Oct 2026 | $0.712 |
| Sep 2026 | $0.802 |
| Aug 2026 | $0.883 |
| Jul 2026 | $0.898 |
| Jun 2026 | $0.809 |
| May 2026 | $0.691 |
| Apr 2026 | $0.678 |
| Mar 2026 | $0.759 |
| Feb 2026 | $0.967 |
| Jan 2026 | $0.919 |
| Dec 2025 | $0.817 |
| Nov 2025 | $0.741 |
| Oct 2025 | $0.816 |
| Sep 2025 | $0.884 |
| Aug 2025 | $0.791 |
| Jul 2025 | $0.708 |
| Jun 2025 | $0.624 |
| May 2025 | $0.590 |
| Apr 2025 | $0.600 |
| Mar 2025 | $0.735 |
| Feb 2025 | $0.697 |
| Jan 2025 | $0.618 |
| Dec 2024 | $0.529 |
| Nov 2024 | $0.405 |
| Oct 2024 | $0.689 |
| Sep 2024 | $0.661 |
| Aug 2024 | $0.691 |
| Jul 2024 | $0.428 |
| Jun 2024 | $0.715 |
| May 2024 | $0.491 |
| Apr 2024 | $0.555 |
| Mar 2024 | $0.639 |
| Feb 2024 | $0.665 |
| Jan 2024 | $0.846 |
| Dec 2023 | $0.663 |
| Nov 2023 | $0.681 |
| Form | Strength | Version | What pharmacies pay | |
|---|---|---|---|---|
| Tablet · Oral | ESTRADIOL 0.5 mg/1; NORETHINDRONE ACETATE 0.1 mg | Generic | $0.593 per tablet | NDC details & price history |
| Tablet · Oral | ESTRADIOL 1 mg/1; NORETHINDRONE ACETATE 0.5 mg | Generic | $0.549 per tablet | NDC details & price history |
| Skin patch · Transdermal | ESTRADIOL 0.05 mg/d; NORETHINDRONE ACETATE 0.14 mg/d | Brand name | $31.80 each | NDC details & price history |
| Skin patch · Transdermal | ESTRADIOL 0.05 mg/d; NORETHINDRONE ACETATE 0.25 mg/d | Brand name | $31.79 each | NDC details & price history |
Source: CMS National Average Drug Acquisition Cost (NADAC). Each row spans the package sizes CMS priced; the generic and the brand are priced separately.
Estradiol / Norethindrone Brand Names
Estradiol / Norethindrone has 7 brand names on record: Lopreeza, Activella, Etyqa, Abigale and others. A brand name is one company's name for the medicine; a generic has the same active ingredient under its generic name.
Who Makes Estradiol / Norethindrone: Manufacturers and Labelers
10 companies list Estradiol / Norethindrone products with the FDA. By number of product records, the largest are Amneal Pharmaceuticals NY LLC, A-S Medication Solutions, Amneal Pharmaceuticals LLC. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.
Sources for This Estradiol / Norethindrone Page
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How this page is built
HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Amneal Pharmaceuticals LLC is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →